About the Authors
- Rob Hooft van Huijsduijnen
-
Affiliation Medicines for Malaria Venture (MMV), Geneva, Switzerland
- R. Kiplin Guy
-
Affiliation St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
- Kelly Chibale
-
Affiliation Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa
- Richard K. Haynes
-
Affiliation Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa
- Ingmar Peitz
-
Affiliation Oncotest GmbH, Freiburg, Germany
- Gerhard Kelter
-
Affiliation Oncotest GmbH, Freiburg, Germany
- Margaret A. Phillips
-
Affiliation Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
- Jonathan L. Vennerstrom
-
Affiliation Department of Pharmaceutical Sciences, Nebraska Medical Center, Omaha, Nebraska, United States of America
- Yongyuth Yuthavong
-
Affiliation BIOTEC, National Science and Technology Development Agency, Thailand Science Park, Pathumthani, Thailand
- Timothy N. C. Wells
-
* E-mail: wellst@mmv.org
Affiliation Medicines for Malaria Venture (MMV), Geneva, Switzerland
Competing Interests
The authors have the following interests. Ingmar Peitz and Gerhard Kelter are employed by Oncotest GmbH. Medicines for Malaria Venture is involved in supporting the development of some of these medicines. There are no patents or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TNCW RHvH IP GK. Performed the experiments: IP GK. Analyzed the data: RHvH TNCW IP GK. Contributed reagents/materials/analysis tools: RKG KC RKH MAP JLV YY. Wrote the paper: RHvH.